Cochlear

Cochlear Limited is a global leader in implantable hearing solutions, dedicated to helping people with moderate to profound hearing loss lead full and active lives. Headquartered in Sydney, Australia, the company designs, manufactures, and supplies a range of advanced hearing devices, including cochlear implants, bone conduction systems, and acoustic implants. With a presence in over 180 countries, Cochlear has provided more than 750,000 implantable devices to recipients worldwide, significantly impacting the field of otolaryngology and audiology. The company operates at the intersection of medical technology and life-changing innovation, investing heavily in research and development to improve sound processing, connectivity, and surgical outcomes. By fostering close collaborations with clinicians, researchers, and the hearing-impaired community, Cochlear continues to push the boundaries of what is possible in hearing restoration, maintaining its position as a pioneer in the medical device industry.

Mission: To help people hear and be heard. Vision: To be the global leader in implantable hearing solutions.

• Invented the world's first multi-channel cochlear implant.
• Consistently ranked among the top medical device innovators globally.
• Provides lifelong support and connectivity upgrades for recipients.
• Extensive global network of clinical and research partnerships.

Sources

• Cochlear Official Website
• ASX Market Data